Comparison of Pain Relief After Arthroscopic Knee Surgery: Adductor Canal Block and Genicular Nerve Block

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-72
SponsorBaşakşehir Çam & Sakura City Hospital

About this trial

This prospective randomized study aims to compare the analgesic efficacy of Adductor Canal Block (ACB) and Genicular Nerve Block (GNB) groups to relieve postoperative pain in participants between ages of 18-72 undergoing arthroscopic knee surgery under spinal anesthesia. The main question it aims to answer is:

To demonstrate whether Adductor Canal Block or Genicular Nerve Block is more effective in postoperative analgesia in patients undergoing arthroscopic knee surgery based on pain scores, opioid consumption and patient satisfaction.

Arthroscopic knee surgeries cause severe pain especially with movement in the post-operative period. After surgery, the movements of the participants are severely restricted because of pain, which increases the possibility of complications and postpones post-operative knee exercises. In this study, the participants' pain status, VAS score, opioid consumption and patient satisfaction will be measured with a simple scoring system for 24 hours at predetermined time points and then compared. Both types of blocks have pain-relieving effects. This study will only investigate which one is more effective in reducing pain, and there will be no deficiency in relieving the pain of the participants.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Voluntary willingness to participate in the study.

Patients undergoing arthroscopic knee surgery (meniscus, ACL, arthroscopic intervention etc).

ASA I-II-III classification.

Aged between 18-72 years.

Disqualifiers

Undergoing surgery under general anesthesia.

Chronic analgesic use.

Presence of an active infection at the procedure site.

Outside the appropriate age range.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Adductor Canal Block (ACB)

    Procedure/Surgery

    Evaluation of postoperative analgesic effectiveness of ACB block in participants undergoing arthroscopic knee surgery under spinal anesthesia.

  • Genicular Nerve Block (GNB)

    Procedure/Surgery

    Evaluation of postoperative analgesic effectiveness of GNB block in participants undergoing arthroscopic knee surgery under spinal anesthesia.

Treatment groups

68 Participants
are divided into 2 treatment groups
Group A: ACB GroupActive comparator 1 intervention
Group B: Genicular Nerve BlockActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Effectiveness on Pain Scores (NRS)

Postoperative pain assessment is performed using the Numerical Rating Scale (NRS). Participants are asked about their rest pain at Baseline 0, postoperative 1st, 2nd, 4th, 6th, 12th, and 24th hours after applying a preoperative peripheral nerve block. With this method, participants rate their pain with a precise numerical value from 0 to 10. While zero(0) represents "no pain"; Ten (10) represents the opposite end of the pain continuum (e.g., "The most intense pain imaginable," "As intense pain as possible," "Maximum pain").

Time frame
Postoperative 24 hours

Secondary outcomes

1

Amount of rescue analgesia administration

After the surgery all patients will be given 4 times a day Paracetamol 1 gram. Patients who still have pain (NRS 4 or higher) will be given Tramadol 1 mg/kg (maximum 400 mg Tramadol daily). Postoperative 24 hours the amount of the rescue analgesic (Tramadol) will be noted.

Time frame
Postoperative 24 hours.
2

Postoperative Blood pressure

Participants' blood pressure (mm/hg) will be monitored for 24 hours (Post op 1st, 2nd, 4th, 6th, 12th and 24th hours) postoperatively.

Time frame
Postoperative 24 hours
3

Length of hospital stay

Length of hospital stay will be noted.

Time frame
Postoperative 14 days
4

First Time Of Mobilisation/Exercise

First time of mobilisation/exercise will be noted.

Time frame
Postoperative 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.